HSHL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
HSHL FAQ
What was Home Solutions Health Inc’s price range in the past 12 months?
Currently, no data Available
What is Home Solutions Health Inc’s market cap?
Home Solutions Health Inc’s market cap is $246.00.
When is Home Solutions Health Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Home Solutions Health Inc’s earnings last quarter?
Currently, no data Available
Is Home Solutions Health Inc overvalued?
According to Wall Street analysts Home Solutions Health Inc’s price is currently Overvalued.
Does Home Solutions Health Inc pay dividends?
Home Solutions Health Inc does not currently pay dividends.
What is Home Solutions Health Inc’s EPS estimate?
Home Solutions Health Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Home Solutions Health Inc have?
Home Solutions Health Inc has 246,000,000 shares outstanding.
What happened to Home Solutions Health Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Home Solutions Health Inc?
Currently, no hedge funds are holding shares in HSHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Home Solutions Health Inc
Home Solutions Health Inc. focuses on the creation, advertising, and distribution of various health-related goods. Among its product offerings is Hemorrelief. This enterprise commenced operations in 1996 and its primary business location is in New York, NY.
INVO Fertility
―
NewcelX
―
NewGenIvf Group
―
Virax Biolabs Group Ltd. Class A
―
Mobile-health Network Solutions Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors